ES2054657T3 - Nuevos oligosacaridos y su metodo de preparacion. - Google Patents

Nuevos oligosacaridos y su metodo de preparacion.

Info

Publication number
ES2054657T3
ES2054657T3 ES87202625T ES87202625T ES2054657T3 ES 2054657 T3 ES2054657 T3 ES 2054657T3 ES 87202625 T ES87202625 T ES 87202625T ES 87202625 T ES87202625 T ES 87202625T ES 2054657 T3 ES2054657 T3 ES 2054657T3
Authority
ES
Spain
Prior art keywords
preparation
oligosaccharides
ribitol
ribose
phosphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87202625T
Other languages
English (en)
Inventor
Eduard Coen Beuvery
Adolf Evenberg
Jan Theunis Poolman
Boom Jacobus Hubertus Van
Peter Hoogerhout
Boeckel Constant Adriaan A Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nederlanden Staat
Nederlanden Volksgezondheid Welzijn en Sport VWS
Original Assignee
Nederlanden Staat
Nederlanden Volksgezondheid Welzijn en Sport VWS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nederlanden Staat, Nederlanden Volksgezondheid Welzijn en Sport VWS filed Critical Nederlanden Staat
Application granted granted Critical
Publication of ES2054657T3 publication Critical patent/ES2054657T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS OLIGOSACARIDOS QUE CONTIENEN LA ESTRUCTURA (D-RIBOSA-D-RIBITOL-FOSFATO)M, (D-RIBITOL-FOSFATO-D -RIBOSA)M O (FOSFATO-D-RIBOSA-D-RIBITOL)M, EN LA QUE M PUEDE VALER DESDE 2 HASTA 20, A INMUNOGENOS QUE CONTIENEN DICHOS OLIGOSACARIDOS, A VACUNAS QUE CONTIENEN ESTOS INMUNOGENOS Y A METODOS PARA SU PREPARACION. LA VACUNA ES MUY ADECUADA PARA EL TRATAMIENTO DE INFECCIONES CAUSADAS POR HAEMOPHILUS INFLUENZAE DE TIPO B.
ES87202625T 1986-12-31 1987-12-28 Nuevos oligosacaridos y su metodo de preparacion. Expired - Lifetime ES2054657T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8603325 1986-12-31

Publications (1)

Publication Number Publication Date
ES2054657T3 true ES2054657T3 (es) 1994-08-16

Family

ID=19849078

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87202625T Expired - Lifetime ES2054657T3 (es) 1986-12-31 1987-12-28 Nuevos oligosacaridos y su metodo de preparacion.

Country Status (15)

Country Link
US (1) US5034519A (es)
EP (1) EP0276516B1 (es)
JP (1) JPS63190896A (es)
KR (1) KR880007557A (es)
AT (1) ATE87003T1 (es)
AU (1) AU603405B2 (es)
CA (1) CA1335405C (es)
DE (1) DE3784907T2 (es)
DK (1) DK694687A (es)
ES (1) ES2054657T3 (es)
FI (1) FI89172C (es)
IE (1) IE59734B1 (es)
NO (1) NO169775C (es)
NZ (1) NZ223009A (es)
PT (1) PT86484B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0320942A3 (en) * 1987-12-18 1989-10-04 American Cyanamid Company Novel polysaccharides novel macromolecular conjugates of the polysaccharides
ATE105189T1 (de) * 1988-04-19 1994-05-15 American Cyanamid Co Haemophilus influenzae typ b polysaccharidaussermembranprotein-konjugat als impfstoff.
US7118757B1 (en) * 1988-12-19 2006-10-10 Wyeth Holdings Corporation Meningococcal class 1 outer-membrane protein vaccine
EP0378929A3 (en) * 1988-12-23 1990-08-01 Connaught Laboratories Limited Membrane proteins and peptides of haemophilus influenzae type b
GB8924473D0 (en) * 1989-10-31 1989-12-20 Connaught Lab Outer membrane protein p1 and peptides of haemophilus influenzae b
NZ239643A (en) * 1990-09-17 1996-05-28 North American Vaccine Inc Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
US5153312A (en) * 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
ES2131066T3 (es) * 1990-12-21 1999-07-16 Antex Biolog Inc Vacuna de conjugacion de oligosacarido con adhesina para hi(haemophilus influenzae).
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
CA2059693C (en) * 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
US5409705A (en) * 1991-05-20 1995-04-25 Kao Corporation Phosphobetaine and detergent and cosmetic containing the same
US5371197A (en) * 1991-09-24 1994-12-06 Merck & Co., Inc. Protein-dimeric polysaccharide conjugate vaccine
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
WO1994000152A1 (en) * 1992-06-25 1994-01-06 Georgetown University Papillomavirus vaccines
US7148031B2 (en) 1994-07-26 2006-12-12 The Mitre Corporation Sequestering of glycoprotein molecules and oligosaccharide moieties in lipo-glycoprotein membranes and micelles
US5782396A (en) 1995-08-28 1998-07-21 United States Surgical Corporation Surgical stapler
US5762256A (en) 1995-08-28 1998-06-09 United States Surgical Corporation Surgical stapler
US6032849A (en) * 1995-08-28 2000-03-07 United States Surgical Surgical stapler
SE9601158D0 (sv) * 1996-03-26 1996-03-26 Stefan Svenson Method of producing immunogenic products and vaccines
WO1998008543A1 (en) * 1996-08-27 1998-03-05 Chiron Corporation Neisseria meningitidis serogroup b glycoconjugates and methods of using the same
US6267961B1 (en) * 1996-11-22 2001-07-31 Baxter International Inc. Direct methods for molar-mass determination of fragments of Haemophilus influenzae type b capsular polysaccharides and vaccine preparation
CU22904A1 (es) * 1999-08-30 2004-01-23 Univ De Ottawa Oligosacáridos derivados de ribosa- ribitol-fosfato, métodos para prepararlos, inmunógenos que los comprenden y vacunas que comprenden dichos inmunógenos
US8785134B2 (en) 2008-11-10 2014-07-22 The Mitre Corporation Glycoprotein vesicles and their methods of use
SG11201811350QA (en) 2016-07-28 2019-01-30 Max Planck Gesellschaft Stable hydrolysis-resistant synthetic polyribosylribitolphosphate derivatives as vaccines against haemophilus influenzae type b
CN108776223B (zh) * 2018-04-19 2021-04-06 广州质量监督检测研究院 紫外吸收剂uv-326检测试剂盒及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220717A (en) * 1977-12-22 1980-09-02 American Cyanamid Company Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
US4264764A (en) * 1979-01-12 1981-04-28 Merck & Co., Inc. Meningitis vaccine
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4451446A (en) * 1982-03-04 1984-05-29 Smithkline-Rit Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
US4644059A (en) * 1982-07-06 1987-02-17 Connaught Laboratories, Inc. Haemophilus influenzae B polysaccharide-diptheria toxoid conjugate vaccine
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
US4459286A (en) * 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine

Also Published As

Publication number Publication date
NZ223009A (en) 1990-06-26
EP0276516A2 (en) 1988-08-03
DE3784907D1 (de) 1993-04-22
FI89172C (fi) 1993-08-25
AU603405B2 (en) 1990-11-15
PT86484A (en) 1988-01-01
CA1335405C (en) 1995-04-25
DK694687D0 (da) 1987-12-30
EP0276516B1 (en) 1993-03-17
NO875442L (no) 1988-07-01
KR880007557A (ko) 1988-08-27
DE3784907T2 (de) 1993-06-24
IE873510L (en) 1988-06-30
FI89172B (fi) 1993-05-14
NO169775C (no) 1992-08-05
AU8314587A (en) 1988-07-07
FI875727A0 (fi) 1987-12-28
PT86484B (pt) 1990-11-20
US5034519A (en) 1991-07-23
JPS63190896A (ja) 1988-08-08
NO875442D0 (no) 1987-12-28
FI875727A (fi) 1988-07-01
DK694687A (da) 1988-07-01
EP0276516A3 (en) 1988-08-17
NO169775B (no) 1992-04-27
IE59734B1 (en) 1994-03-23
ATE87003T1 (de) 1993-04-15

Similar Documents

Publication Publication Date Title
ES2054657T3 (es) Nuevos oligosacaridos y su metodo de preparacion.
FR2499412B1 (fr) Production de vaccin antivirus
PT86318A (en) Process for the preparation of immunogenic proteins
LU91610I2 (fr) Protéine D et ses dérivés pharmaceutiquement acceptables (SYNFLORIX - Vaccin pneumococcique polysaccharidique conjugé (adsorbé)
LTIP1794A (en) Method for the production of an aids virus vaccine
ATE132904T1 (de) Verfahren zur herstellung von trehalulose und isomaltulose
FR2599626B1 (fr) Antigene du flavivirus, procede pour sa production et vaccin le contenant
PT85221A (en) Improved stabilizers for live vaccines process for their preparation and vaccines containing them
HUT43792A (en) Process for production of combined vaccine
EP0268640A4 (en) VACCINE STIMULATING OR IMPROVING THE PRODUCTION OF ANTIBODIES AGAINST GM2.
GR1001125B (el) Μεθοδος δια την εις βιομηχανικη κλιμακα παραγωγην της βμυ 21502.
PT87301A (pt) Process for the preparation of 1,3-dioxanes by products and of pharmaceutical compounds containing them
PT88420A (pt) Process for the preparation of pharmaceutical compositions containing 1-(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-5-ethyluracil and a method for treating hepatitis virus infections by using said compositions
FI871131A (fi) Menetelmä rokotteen valmistamiseksi
DE3364803D1 (en) Method of preparing an immunogen of pasteurella multocida
HUT43107A (en) Process for producing vaccine against melanome
FR2594955B1 (fr) Agent de diagnostic, son procede de preparation et sa methode d'emploi
PT86745A (pt) Process for preparing oxime ethers of 2,6-dioxabicyclo ]3.3.o" octanones
PT85189A (fr) Procede de preparation de n-imidazolymethyl-diphenylazomethines et leur application en therapeutique
PT85365A (de) Verfahren zur herstellung von 1,4-dihydropyridin-3-carbonsaurephenoxyaliphatyphenylenoxyalkylester
PT88465A (pt) Process for the preparation of macrolide compounds
PT85284A (fr) Procede de preparation de fractions antigeniques exocellulaires de bordetella pertussis et vaccin contre la co-ueluche contenant de telles fractions
BG41376A1 (en) Method for preparing modified hydrolysate of polyacrylnitrile
IT8321578A0 (it) Processo per la preparazione di 3,3' - o 3,4'-diamminobenzofenone.
ZA879678B (en) New oligosaccharides,immunogens and vaccines,and methods for preparing such oligosaccharides,immunogens and vaccines

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 276516

Country of ref document: ES